Article
Phenotypic proteomic profiling identifies a landscape of targets for circadian clock-modulating compounds.
Life science alliance - 1 Dec 2019
Ray Sandipan, Lach Radoslaw, Heesom Kate J, Valekunja Utham K, Encheva Vesela, Snijders Ambrosius P, Reddy Akhilesh B
Abstract excerpt
Determining the exact targets and mechanisms of action of drug molecules that modulate circadian rhythms is critical to develop novel compounds to treat clock-related disorders. Here, we have used phenotypic proteomic profiling (PPP) to systematically determine molecular targets of four circadian period-lengthening compounds in human cells. We demonstrate that the compounds cause similar changes in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
